CompletedPhase 2NCT00593710

Losartan Versus Atenolol for the Treatment of Marfan Syndrome

Studying Marfan syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of British Columbia
Principal Investigator
George Sandor, MD, FRCPC
University of British Columbia
Intervention
Losartan(drug)
Enrollment
17 enrolled
Eligibility
12-25 years · All sexes
Timeline
20082011

Study locations (1)

Collaborators

Heart and Stroke Foundation of Canada

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00593710 on ClinicalTrials.gov

Other trials for Marfan syndrome

Additional recruiting or active studies for the same condition.

See all trials for Marfan syndrome

← Back to all trials